abs54.txt	epstein-barr	virus	(ebv)	is	convincingly	associated	with	gastric	cancer	nasopharyngeal	carcinoma		and	certain	lymphomas		but	its	role	in	other	cancertypes	remains	controversial		to	test	the	hypothesis	that	there	are	additionalcancer	types	with	high	prevalence	of	ebv		we	determined	ebv	viral	expression	inall	the	cancer	genome	atlas	project	(tcga)	mrna	sequencing	(mrna-seq)	samples	(n=	10	396)	from	32	different	tumor	types		we	found	that	ebv	was	present	in	gastricadenocarcinoma	and	lymphoma		as	expected		and	was	also	present	in	>5%	of	samplesin	10	additional	tumor	types		for	most	samples		ebv	transcript	levels	were	low	which	suggests	that	ebv	was	likely	present	due	to	infected	infiltrating	b	cells	in	order	to	determine	if	there	was	a	difference	in	the	b-cell	populations		weassembled	b-cell	receptors	for	each	sample	and	found	b-cell	receptor	abundance	(p≤	1	4	×	10-20)	and	diversity	(p	≤	8	3	×	10-27)	were	significantly	higher	inebv-positive	samples		moreover		diversity	was	independent	of	b-cell	abundance	suggesting	that	the	presence	of	ebv	was	associated	with	an	increased	and	alteredb-cell	population		importance	around	20%	of	human	cancers	are	associated	withviruses		epstein-barr	virus	(ebv)	contributes	to	gastric	cancer		nasopharyngealcarcinoma		and	certain	lymphomas		but	its	role	in	other	cancer	types	remainscontroversial		we	assessed	the	prevalence	of	ebv	in	rna-seq	from	32	tumor	typesin	the	cancer	genome	atlas	project	(tcga)	and	found	ebv	to	be	present	in	>5%	ofsamples	in	12	tumor	types		ebv	infects	epithelial	cells	and	b	cells	and	in	bcells	causes	proliferation		we	hypothesized	that	the	low	expression	of	ebv	inmost	of	the	tumor	types	was	due	to	infiltration	of	b	cells	into	the	tumor		theincrease	in	b-cell	abundance	and	diversity	in	subjects	where	ebv	was	detected	inthe	tumors	strengthens	this	hypothesis		overall		we	found	that	ebv	was	associatedwith	an	increased	and	altered	immune	response		this	result	is	not	evidence	ofcausality		but	a	potential	novel	biomarker	for	tumor	immune	status	
